Thrivent Financial for Lutherans’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $969K | Buy |
+36,564
| New | +$969K | ﹤0.01% | 1796 |
|
|
2025
Q1 | – | Sell |
-27,591
| Closed | -$1.11M | – | 2557 |
|
|
2024
Q4 | $1.11M | Sell |
27,591
-660
| -2% | -$26.6K | ﹤0.01% | 1836 |
|
|
2024
Q3 | $1.79M | Buy |
28,251
+748
| +3% | +$47.4K | ﹤0.01% | 1524 |
|
|
2024
Q2 | $1.46M | Buy |
27,503
+55
| +0.2% | +$2.92K | ﹤0.01% | 1606 |
|
|
2024
Q1 | $2.25M | Buy |
+27,448
| New | +$2.25M | ﹤0.01% | 1322 |
|
|
2021
Q1 | – | Sell |
-11,376
| Closed | -$64K | – | 2578 |
|
|
2020
Q4 | $64K | Hold |
11,376
| – | – | ﹤0.01% | 2446 |
|
|
2020
Q3 | $66K | Hold |
11,376
| – | – | ﹤0.01% | 2353 |
|
|
2020
Q2 | $82K | Sell |
11,376
-70,005
| -86% | -$505K | ﹤0.01% | 2269 |
|
|
2020
Q1 | $381K | Buy |
+81,381
| New | +$381K | ﹤0.01% | 1867 |
|